ReportsnReports – Market and Product Forecasts: Systemic Lupus Erythematosus
With its first-to-market status and an additional subcutaneous formulation in the pipeline, Datamonitor forecasts Benlysta to achieve and maintain market dominance over the next 10 years. Datamonitor forecasts four additional products to launch over the next 10 years, significantly altering the lupus market, and reaching sales of over $4bn in the US and five major EU markets by 2020.
View full press release